EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stroke: Epidemiology, Risk Factors, Signaling Pathways, and Clinical Management

He Ren, Yuchun Liu, Mingyue Zhao, Hangyu Shen, Sheng Nie, Xiang Gao, Yi Huang iD

MedComm · 2025-12 · 6 (12)

DOI: 10.1002/mco2.70558 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 17.12.2025. Verfasst von He Ren und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine Zhejiang University Hangzhou Zhejiang China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 779 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Natural Science Foundation of Ningbo Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stroke can be classified into ischemic stroke (IS), hemorrhagic stroke (HS), and subarachnoid hemorrhage. The high incidence, disability, and mortality rates, especially from IS, place a huge burden on global health. The pathophysiological processes following IS mainly involve energy deficiency, ion homeostasis imbalance, oxidative stress, neuroinflammation, programmed cell death, blood–brain barrier disruption, and cerebral edema. Transient ischemic attack is an early warning sign of IS, characterized by temporary neurological deficits. HS mainly involves primary damage caused by the mass effect of hematoma and secondary damage caused by the toxic components of hematoma. Although advances in acute‐phase reperfusion technology have reduced mortality, the fundamental challenge of a narrow therapeutic window limits patient eligibility and long‐term recovery outcomes. This review aims to provide a comprehensive overview of stroke, detailing its epidemiology, risk factors, pathophysiological mechanisms, signaling pathways, and clinical management methods. Here, we focus on the latest research progress in IS and emphasize the hope that regenerative therapies, especially stem cell therapies, offer for stroke patients. This review aims to provide a detailed overview of current research and clinical practice in stroke, propose emerging strategies for treating stroke patients, and provide an outlook on future research directions in this field.

Schlagwörter

Stichwörter der Autor:innen

cell transplantationclinical managementclinical treatmentneuroprotectionrisk factorssignaling pathwaysstem cellsstroke

Autor:innen und Institutionen

  • School of Medicine Zhejiang University Hangzhou Zhejiang China.
  • Department of Neurosurgery Ningbo Key Laboratory of Nervous System and Brain Function The First Affiliated Hospital of Ningbo University Ningbo Zhejiang China.

ORCID-Profile: Yi Huang

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Natural Science Foundation of Ningbo Municipality

Zitieren

APA

Ren, H., Liu, Y., Zhao, M., Shen, H., Nie, S., Gao, X., & Huang, Y. (2025). Stroke: Epidemiology, Risk Factors, Signaling Pathways, and Clinical Management. MedComm, 6(12). https://doi.org/10.1002/mco2.70558

Vancouver

Ren H, Liu Y, Zhao M, Shen H, Nie S, Gao X, et al. Stroke: Epidemiology, Risk Factors, Signaling Pathways, and Clinical Management. MedComm. 2025;6(12). doi:10.1002/mco2.70558

BibTeX
@article{Ren2025,
  author = {Ren, He and Liu, Yuchun and Zhao, Mingyue and Shen, Hangyu and Nie, Sheng and Gao, Xiang and Huang, Yi},
  title = {Stroke: Epidemiology, Risk Factors, Signaling Pathways, and Clinical Management},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {12},
  doi = {10.1002/mco2.70558}
}
Kostenlos starten →